News | FDA | October 07, 2026

FDA clearance advances MRI-only spine workflows using the patient’s standard diagnostic MRI.

MRI2CT Receives FDA Clearance for AI-Powered Imaging Platform

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating accurate 3D bone visualization of the lumbar spine and sacrum directly from a patient’s standard diagnostic MRI.

The FDA clearance marks an important step toward MRI2CT’s vision of MRI-only workflows in spine care. Using the MRI already acquired as part of the patient’s diagnostic path, NextMR provides detailed 3D bone morphology without exposing the patient to additional radiation, creating a more streamlined pathway from initial imaging through surgical planning and execution.

“Patients commonly begin their spine journey with an MRI, while detailed 3D visualization of bone may require another imaging step,” said Shmulik Shpiro, CEO of MRI2CT. “NextMR changes that paradigm. Our vision is an MRI-only workflow that simplifies the patient journey and connects the standard diagnostic MRI more seamlessly with planning and surgical enabling technologies.”

NextMR works with routine conventional MRI sequences acquired on 1.5T and 3T scanners and automatically generates its 3D bone output in under 60 seconds. Clinicians can view the output in sagittal, coronal and axial planes and as a three dimensional reconstruction through the MRI2CT web interface or compatible DICOM environments. The secure, cloud-based application requires no local software installation.

“NextMR gives us the ability to take the routine MRI a patient already has and transition directly to highly accurate 3D bone morphology that can support the surgical workflow. That’s a huge advantage,” said Dr. Frank Phillips, Professor, Director, Section of Minimally Invasive Spine Surgery at Midwest Orthopaedics at Rush in Chicago. “For patients, that can mean avoiding additional imaging, radiation and appointments while helping streamline their path to surgery.”

NextMR was validated on an independent retrospective dataset of 145 adults with paired MRI and CT imaging from sites in the United States and Israel, demonstrating submillimeter cortical delineation accuracy across multiple patient subgroups.

 

MRI2CT FDA

 


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Ultrasound Imaging

Oct. 28, 2026 — Clarius Mobile Health has announced 30 specialized AI models are now integrated into Clarius App 13.1 ...

Time November 02, 2026
arrow
News | Lung Imaging

Nov.2, 2026 – SimonMed has announced the clinical launch of two advanced lung imaging technologies, CT:VQ and LDAf, in ...

Time November 02, 2026
arrow
News | Women's Health

Oct. 29, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive ...

Time October 30, 2026
arrow
News | X-Ray

Oct. 27, 2026 — AZmed has announced that its FDA-cleared AZtrauma and AZchest X-ray AI applications are available ...

Time October 29, 2026
arrow
Subscribe Now